Kamal Ghorui
Stock market recommendations: Mtar Technologies, and Syrma SGS have been picked as the top stocks to buy in the holiday-shortened trading week starting from April 13, 2026, by Motilal Oswal Wealth Management Research Desk. Let’s look at the details:
Mtar TechnologiesMTAR Technologies (MTARTECH) is a precision engineering company serving niche, high-barrier industries across defense, aerospace, nuclear energy, and clean energy with a growing exposure to global fuel cell technology through its decadelong partnership with Bloom Energy (BE). MTARTECH is emerging as an indirect beneficiary of the global AI-driven data center expansion, with ~100 GW of new capacity expected during 2026–2030. Bloom Energy’s rapid SOFC deployment and strong backlog position it to capitalize on this accelerating infrastructure demand. As Bloom Energy’s sole supplier of critical hot box assemblies, MTARTECH holds a deeply entrenched, hard-to-replace position in the supply chain. With rising BE orders, MTAR could secure ₹27–53b cumulative inflows over 3–5 years, significantly strengthening its revenue visibility. We expect it to post a CAGR of 40%/55%/78% in revenue/EBITDA/ adj. PAT over FY25-28.Syrma SGSSyrma SGS Technology is an electronics manufacturing services (EMS) provider offering design-led solutions across industries, while strategically shifting toward higher-margin segments like automotive, industrial, IT, and railways. Its focus on complex, low-volume manufacturing and diversified orders supports sustained margin expansion and scalable growth. The company is witnessing strong underlying growth drivers from broad-based demand across key industries, complemented by operating leverage, cost optimization initiatives. Improving execution capabilities and steadily strengthening order pipeline enhance revenue visibility, positioning business for consistent expansion across both domestic and export markets. Syrma’s outlook remains strong, supported by a robust order book, rising exports, Elcome acquisition, and PCB entry. It is expected to deliver revenue/EBITDA/PAT CAGR of ~30%/45%/52% over FY25–28, indicating sustained growth momentum. (Disclaimer: Recommendations and views on the stock market, other asset classes or personal finance management tips given by experts are their own. These opinions do not represent the views of The Times of India)
